Company: REVB
Filing Date: 2025-05-20
Form Type: S-1
Source: 0001213900-25-045828
Chunk: 225

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-20
Form: S-1
Chunk 225
---
 legal proceedings, nor is it aware of any material pending or threatened litigation. F-34 5. 2024 Financings February Public Offering On February 5, 2024, the Company closed a public offering of 85,311shares of its common stock and warrants to initially purchase up to 170,628shares of common stock with an initial exercise price of $ 72.48which expire on February 5, 2029. Net cash proceeds to the Company from the offering were $ 5.4million and issuance costs were $ 0.8million including placement agent fees. The shares of common stock issued in the offering and the shares of common stock underlying the Class D Pre-Funded Warrants and the Class D Common Stock Warrants were registered with the SEC on Form S-1, which was declared effective by the SEC on January 31, 2024. Class D Warrant Inducement On August 21, 2024, the Company entered into warrant exercise inducement offer letters with certain holders of Class D Common Stock Warrants exercisable for an aggregate of 159,249shares of its common stock, at a reduced exercise price of $ 20.00per share. In exchange, the Company agreed to issue twoClass E Common Stock Warrants for each Class D Common Stock Warrant exercised in the private placement pursuant to Section 4(a)(2) of the Securities Act of 1933. In connection with the warrant inducement, the Company paid Roth Capital Partners, LLC (“Roth”) a cash fee of $ 267,546for its services. The Company received net cash proceeds of approximately $ 3.5million and issuance costs of $ 0.3million. The shares of common stock issued from the exercise of the Class D Common Stock Warrants were registered on Form S-1 and declared effective by the SEC on January 31, 2024. The Class E Common Stock Warrants offered in the private placement were registered on Form S-3 with the SEC and declared effective on September 12, 2024. Class E Warrant Inducement On December 3, 2024, the Company entered into warrant exercise inducement offer letters with certain holders of the Class E Common Stock Warrants exercisable for an aggregate of 254,002shares of common stock with an exercise price of $ 16.00per share. In exchange, the Company agreed to issue Class F Common Stock Warrants exercisable for 254,